Proto-oncogenes (H-ras-1 and L-myc) and tumor-suppressor gene (p53) loci have been implicated in lung carcinogenesis. DNA restriction fragment length polymorphisms at these gene loci are being evaluated in a case-control study as markers predictive of risk for cancer or of prognosis when cancer is present. The cases and controls had a cigarette-smoking history of 40 or more pack years or other abnormalities in pulmonary function tests, their ages were closely matched (64 years for cases and 61 years for controls) and the ratio of Caucasians to African Americans was close to unity (cases, 0.95:100, controls, 1.00:0.88). The H-ras-1 gene contains an insertion deletion polymorphism. Inheritance of rare H-ras-1 alleles, defined by MspI digestion, confers a relative risk for lung cancer of 2.0 (95% confidence interval, 0.5-7.3) for Caucasians and 3.2 (0.9-11.6) for African Americans (74 cases, 67 controls). The L-myc gene sequence has a restriction site (EcoRl) polymorphism between the second and third exons. Inheritance of restriction site-present alleles was reported to confer poor prognosis (presence of lymph node metastases) in Japanese lung cancer patients. This hypothesis was tested in both case-control study subjects (56 cases, 55 controls) and additional surgical cases (40), but no evidence was found to support the hypothesis in the U.S. population. The p53 gene is a tumorsuppressor gene that can encode either a proline or an arginine in the 72nd residue. No associations was found between the minor allele (proline) and diagnosis of lung cancer (76 cases, 68 controls). Importantly, the observed allelic distributions at each of these genetic loci (H-ras-1, L-myc, and p53) were found to be significantly different between African Americans and Caucasians in a U.S. population.
Introduction
Epidemiological and pharmacogenetic studies have postulated the existence of inherited predisposition for lung cancer (1, 2) . Furthermore, familial studies suggest a genetic component to this disease, in spite of its now well documented environmental etiology [tobacco smoking (3) ]. Few useful genetic markers exist, however, that allow assessment of individual risk for of human lung cancer. The biomarkers evaluated in the current study consist of proto-oncogenes and tumor-suppressor genes that are implicated in the genesis human lung cancer: H-ras-1 (4), L-myc (5) , and p53 (6) . A growing number ofinvestigations by others have attempted to evaluate various potential biomarkers of individual cancer risk, but most of these suffer from inadequate study design. With respect to lung cancer, case-control studies are of limited value if age and tobacco smoking history are not controlled. The studies reported here were undertaken in the context of a formal case-control design that accounts for age, tobacco smoking history, gender, ethnic background, occupational history, and familial history of cancer.
Materials and Methods

Accrual of Study Subjects
The design of this epidemiological case-control study of lung cancer is described in detail elsewhere (7) . Briefly, patients with histologically confirmed lung cancer who had not received radiation or chemotherapy were recruited at the University of Maryland and Baltimore Veterans Administration Hospitals between 1985 and 1989 . Histological diagnosis of lung cancer was confirmed by pathological review. Two control groups were recruited: chronic obstructive pulmonary disease (COPD) patients and patients with cancers at anatomical sites other than the lung and bladder. The CACAT3'-* and +-5'TGCATATCAGGAAGCTTGAG3').
The PCR was performed using a DNA thermal cycler (Perkin-Elmer Cetus, Emeryville, CA), amplified DNA segments were digested with EcoRI and subjected to electrophoresis in polyacrylamide gels (8%) (New England Biolabs, Beverly, MA). The gels were treated with an ethidium bromide solution and examined under ultraviolet light. A representative subset of samples was analyzed by Southern hybridization with the 1.9-kb EcoRV/SmaI fragment of an L-myc cDNA clone to corroborate the PCR-RE analyses (10) .
Polymerase Chain Reaction-Restriction Enzyme Analysis for p53
An easy PCR-RE genotyping test was developed on the basis of previous reports (11, 12) . The method used here, however, included an important modification: the primer flanking codon 72 in the 5' region contained a single basepair mismatch (resulting in the formation of a new AccII restriction site between exon 2 and exon 3; that is, an A to C change at nucleotide position 11863 of p53) to control for completion of digestion. DNA samples were amplified for 35 cycles using a standard protocol (13) either with primers 1 and A (below) or by a hemi-nested strategy using primers 1 
Results
Analysis of the H-ras-1 Polymorphism
Twenty-three discrete restriction fragments (MspI) were found in 141 study subjects for the H-ras-1 protooncogene. Resolution of 13 of these restriction fragments is shown in Figure 1, 142 bp -125 bp FIGURE 2. Southern blot analysis (A, B, C) and polymerase chain reaction (PCR) restriction fragment length polymorphism analysis (D, E, F) of the L-myc proto-oncogene locus. Genomic DNA samples were digested with EcoRI, and immobilized DNA was hybridized to a human 1.9-kb L-myc fragment (A, B, C). Three possible genotypes are shown; the L-L homozygote (A), the S-S homozygote (B) and the L-S heterozygote (C). Samples of DNA that had been produced by the PCR using primers that flank the polymorphic restriction site were digested with EcoRI, electrophoresed in polyacrylamide gels, and stained with ethidium bromide (D, E, F). These figures (D, E, F) were produced by photographing the negative of the ethidium stained-fragment. The corresponding patterns for an L-L homozygote, an S-S homozygote, and an L-S heterozygote are shown in D, E, and FE respectively.
3.9, df = 1, p = 0.05). Adjustment of these results for other risk factors for lung cancer evaluated in this study, for example smoking (pack years), age, family history of lung cancer in first-degree relatives, and the debrisoquine metabolic phenotype, revealed no important confounding factors.
Analysis of the L-myc Polymorphism
Southern blot analysis of human genomic DNA samples that had been digested with EcoRI revealed a DNA restriction fragment length polymorphism consisting of two alleles at the L-myc locus ( Fig. 2A-C) . The PCR was also used to reveal this polymorphism in genomic DNA samples when primers that flank the EcoRI restriction site were used to amplify a DNA segment of267 base pairs (Fig. 2D-F) . Initially, the two methods were applied to the same DNA samples, and it was found that the PCR and Southern hybridization of EcoRI-digested materials gave consistent results (Fig. 2) .
A highly significant difference in allelic distribution between African Americans and Caucasians was found (Table 3) ; the distributions for all subjects was consistent with the Hardy-Weinberg equilibrium (16) . The casecontrol data show that in the Caucasian population the ratio of restriction site-absent alleles (L-alleles) to restriction site-present (S-alleles) was 0.509:0.491, whereas in the African American population the distribution was 0.277:0.763. Similarly, among a group of trauma victims, allele frequencies were 0.562:0.438 and 0.145:0.855 in Caucasians and African Americans, respectively.
In the lung cancer case-control study, PCR-RE or Southern hybridization analyses for L-myc were con- Analysis ofp53 Polymorphism Figure 3 shows the strategy for PCR-RE analysis of exon 4 ofp53. Dideoxy-chain termination DNA sequencing of the PCR products was performed to confirm their authenticity (DNA sequencing analysis was performed on a small subset of samples only). PCR analysis with restriction enzyme digestion was performed on 144 study subjects (76 cases and 68 controls). There was no association between presence of the p53 genotype and diagnosis of lung cancer (small-cell and nonsmall-cell combined); however, the observed allelic distribution was significantly different between African Americans and Caucasians (X2 = 20.8, p< 0.0001, df = 2).
Discussion
Molecular epidemiological studies of potential lung cancer risk factors have been described. A case-control study format has been used to evaluate the relationship between risk of developing lung cancer, or prognosis (when lung cancer is present), and genotype at the H-ras-1, L-myc, and p53 gene loci. The results of these studies show that individuals with H-ras-1 rare alleles are at increased risk for lung cancer (especially for nonadenocarcinoma in African Americans); that the L-myc genotype is not indicative of lung cancer risk or disease outcome in a U.S. population (prognosis, as measured by performance status, tumor stage, or presence of lymph node metastasis); and that the proline variant of p53 does not appear to predict lung cancer risk. Each ofthese potentially useful biomarkers of lung cancer risk displayed a strong association with race: that is, allelotypic distributions were dependent on the racial origin of the study subjects (African Americans compared to Caucasians). These data indicate that the H-ras-1, L-myc, and p53 polymorphisms should be examined in more detail with regard to their potential as indicators of individual cancer risk, as should the underlying mechanisms that may be responsible for risk of cancer when certain genotypes are inherited. Furthermore, the data indicate the importance of controlling for race as a confounding factor in epidemiological studies.
The underlying mechanistic basis for the contribution of the inheritance of H-ras-1 rare alleles to risk of lung cancer is not known; however, the variable tandem repeat (VTR) region may be involved in somatic-recombinational events, implying that certain types ofVTR are more stable than others (19) . This hypothesis may be extended to VTR regions other than that at the H-ras-1 gene locus. Alternately, VTR regions may have gene enhancer activity (20, 21) , therefore, it follows that certain variants may be more active than others. Notwithstanding the absence of a clear mechanistic basis for the observations reported here, they are supported by the results of a number of other studies (22) (23) (24) , and, although the data in the literature are conflicting (25) , not all studies of lung cancer have controlled for the confounding factors of tobacco smoking and racial background of the study subjects.
It was reported previously, by Kawashima et al. (26) , that the EcoRI restriction site-present allele at the L-myc gene locus (S allele) was an indicator of lymph node metastasis (poor prognosis) in Japanese lung cancer patients. This hypothesis and the hypothesis that inheritance of S alleles is indicative of lung cancer risk have now been tested in two independent studies (10,1 7) . Contrary to the results ofthe study in a Japanese population, neither of the two subsequent studies found associations in Caucasian populations.
L-myc genotyping has been conducted in a variety of cancer groups, mainly of Japanese origin. An association was found in the case of lung (surgical diagnosis) (26) , renal (18) , gastric (27) , and bone cancers (28) between increased frequency of the S allele and advanced disease (metastasis); however, no association was found for lung [clinical diagnosis (26) ], colorectal (29) , or breast cancers (30) . The reasons for these apparently contradictory results are unclear, but a genetic difference related to ethnicity could exist between respective lung cancer populations, even though the allelic frequencies in American Caucasians and Japanese controls do not differ significantly (L:S, 0.562:0.438 versus 0.485:0.515). Future studies which examine this question should control strictly for variation due to race and be designed to eliminate potential bias. Given that allelic frequency varies with ethnicity (L:S, 0.277:0.763 and 0.562:0.438 for African Americans and Caucasians, respectively), if one ethnic group consistently seeks medical attention at a later stage, or is comm posed of an unusual number of prevalent (versus incident) cases, or is associated with a particular histology or exposure, bias could result. In the present study, the prognostic associations considered were similar in Caucasians and African Americans.
For p53, the proline variant of the polymorphism in the coding region is more frequent in African Americans than in Caucasians. No evidence was found, however, for an association between the presence or absence of the proline variant and lung cancer risk.
Tobacco smoke is the major etiological factor in lung cancer, however, not all individuals who smoke cigarettes develop lung cancer, and some individuals with little or no exposure develop lung cancer (31) . These observations suggest that other factors may be important in the determination of lung cancer risk. Using a case-control design, we have evaluated three polymorphic genetic loci (H-ras-1, L-myc, and p53) as potential biomarkers of lung cancer risk. Racial variation in allelic distribution was apparent for each of these polymorphisms, which suggests that controlling for racial variation as a confounding factor in epidemiological studies is an important consideration in study design.
